CH602734A5 - Vincanol derivs - Google Patents
Vincanol derivsInfo
- Publication number
- CH602734A5 CH602734A5 CH1215374A CH1215374A CH602734A5 CH 602734 A5 CH602734 A5 CH 602734A5 CH 1215374 A CH1215374 A CH 1215374A CH 1215374 A CH1215374 A CH 1215374A CH 602734 A5 CH602734 A5 CH 602734A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- compounds
- vincanol
- derivs
- aminoalkyl
- Prior art date
Links
- 229950002496 vincanol Drugs 0.000 title abstract description 5
- HONLKDDLTAZVQV-UHFFFAOYSA-N eburnamine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)N5C2=C1 HONLKDDLTAZVQV-UHFFFAOYSA-N 0.000 title abstract description 4
- HONLKDDLTAZVQV-UHOSZYNNSA-N vincanol Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@H](O)N5C2=C1 HONLKDDLTAZVQV-UHOSZYNNSA-N 0.000 title abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 20
- 229910000039 hydrogen halide Inorganic materials 0.000 claims description 7
- 239000012433 hydrogen halide Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- VKTOXAGUZWAECL-OALUTQOASA-N eburnamenine Natural products C1=CC=C2C(CCN3CCC4)=C5[C@H]3[C@]4(CC)C=CN5C2=C1 VKTOXAGUZWAECL-OALUTQOASA-N 0.000 claims description 6
- VKTOXAGUZWAECL-UHFFFAOYSA-N trans-eburnamenine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)C=CN5C2=C1 VKTOXAGUZWAECL-UHFFFAOYSA-N 0.000 claims description 6
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000007795 chemical reaction product Substances 0.000 claims 1
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 208000009999 tuberous sclerosis Diseases 0.000 abstract description 2
- 206010047095 Vascular pain Diseases 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010062519 Poor quality sleep Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003970 cerebral vascular damage Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 150000002391 heterocyclic compounds Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- SYXYWTXQFUUWLP-UHFFFAOYSA-N sodium;butan-1-olate Chemical compound [Na+].CCCC[O-] SYXYWTXQFUUWLP-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (20)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1215374A CH602734A5 (en) | 1974-09-06 | 1974-09-06 | Vincanol derivs |
| DE19752538095 DE2538095A1 (de) | 1974-09-06 | 1975-08-27 | Neue organische verbindungen, ihre herstellung und verwendung |
| FI752423A FI752423A7 (fr) | 1974-09-06 | 1975-08-28 | |
| DK388475A DK388475A (da) | 1974-09-06 | 1975-08-28 | Fremgangsmade til fremstilling af polycycliske nitrogenholdige forbindelser |
| NO752972A NO752972L (fr) | 1974-09-06 | 1975-08-29 | |
| SE7509657A SE7509657L (sv) | 1974-09-06 | 1975-08-29 | Forfarande for framstellning och anvendning av nya organiska foreningar |
| US05/609,357 US4045443A (en) | 1974-09-06 | 1975-09-02 | Organic compounds |
| NL7510315A NL7510315A (nl) | 1974-09-06 | 1975-09-02 | Werkwijze ter bereiding van nieuwe organische verbindingen. |
| FR7526884A FR2342065A1 (fr) | 1974-09-06 | 1975-09-02 | Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments |
| GB36242/75A GB1518987A (en) | 1974-09-06 | 1975-09-03 | Heterocyclic compounds |
| BE159751A BE833080A (fr) | 1974-09-06 | 1975-09-04 | Nouveaux composes heterocycliques, leur preparation et leur application comme medicaments |
| DD188188A DD121943A5 (fr) | 1974-09-06 | 1975-09-04 | |
| IL48054A IL48054A (en) | 1974-09-06 | 1975-09-04 | 14-deoxy-14-substituted vincanol derivatives their production and pharmaceutical compositions containing them |
| ES440723A ES440723A1 (es) | 1974-09-06 | 1975-09-04 | Procedimiento para la produccion de nuevos compuestos orga- nicos. |
| AU84567/75A AU8456775A (en) | 1974-09-06 | 1975-09-04 | Vinca alkaloids |
| AT685475A ATA685475A (de) | 1974-09-06 | 1975-09-05 | Verfahren zur herstellung neuer vincanol- und epivincanolderivate |
| JP50107161A JPS5154600A (fr) | 1974-09-06 | 1975-09-05 | |
| ZA755697A ZA755697B (en) | 1974-09-06 | 1975-09-05 | Improvements in or relating to organic compounds |
| ES456416A ES456416A1 (es) | 1974-09-06 | 1977-03-01 | Procedimiento para la obtencion de derivados de 14-dioxi- vincanol. |
| US05/788,510 US4123535A (en) | 1974-09-06 | 1977-04-18 | Psychostimulating 14-amino-14,15-dihydroeburnamenines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1215374A CH602734A5 (en) | 1974-09-06 | 1974-09-06 | Vincanol derivs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH602734A5 true CH602734A5 (en) | 1978-07-31 |
Family
ID=4380368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1215374A CH602734A5 (en) | 1974-09-06 | 1974-09-06 | Vincanol derivs |
Country Status (4)
| Country | Link |
|---|---|
| AT (1) | ATA685475A (fr) |
| BE (1) | BE833080A (fr) |
| CH (1) | CH602734A5 (fr) |
| ZA (1) | ZA755697B (fr) |
-
1974
- 1974-09-06 CH CH1215374A patent/CH602734A5/de not_active IP Right Cessation
-
1975
- 1975-09-04 BE BE159751A patent/BE833080A/fr unknown
- 1975-09-05 AT AT685475A patent/ATA685475A/de not_active Application Discontinuation
- 1975-09-05 ZA ZA755697A patent/ZA755697B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA755697B (en) | 1977-04-27 |
| BE833080A (fr) | 1976-03-04 |
| ATA685475A (de) | 1979-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0222693A2 (fr) | Dérivés de 3-oxadiazolyl et 3-acide carboxylique bêta-carboline, leur préparation et leur utilisation comme médicament | |
| EP0013732B1 (fr) | Dérivés d'imidazole, procédés pour leur préparation et compositions pharmaceutiques contenant ces dérivés d'imidazole | |
| EP0008652B1 (fr) | Nouveaux produits intermédiaires et leur utilisation pour la préparation de nouveaux dérivés d'oxadiazolo-pyrimidine | |
| DE2754561A1 (de) | Propionsaeurederivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten | |
| CH602734A5 (en) | Vincanol derivs | |
| CH605949A5 (en) | Vincanol derivs | |
| DE3426533A1 (de) | 1,3,4-thiadiazol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
| DE3025804C2 (de) | 1-S-Alkyl-2-0-acyl-3-phosphocholin-1-mercapto-2,3-propandiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| US3290328A (en) | 2-hydroxymethyl-5-nitroimidazoles and process | |
| US4001425A (en) | Methods of treating hypertension and pharmaceutical compositions comprising 1-tertiary-alkyl-3-(substituted furyl)ureas as antihypertensive agents | |
| DE3242204A1 (de) | Verfahren zur herstellung von aminoalkylfuranen oder -thiophenen | |
| DE2253150B2 (de) | Diastereoisomeres des 1- eckige Klammer auf 1`-(o-Chlorbenzyl)-2`-pyrryl eckige Klammer zu - 2-di-(D,D)-sek.-butylaminoäthanols dessen Salze und Verfahren zur Herstellung dieser Verbindungen | |
| DD247898A5 (de) | Neue heteroaromatische aminderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung | |
| CA1093086A (fr) | Procede d'obtention de ¬1,1-dithien-(3)-yl-1- hydroxy-(3) propyl|-¬1-phenyl-1-hydroxy-(2)- propyl|-amine et de ¬1,1-dithien-(3)-yl-1-propen- (3)-yl|-¬1-phenyl-(2)-propyl|-amine | |
| US3281469A (en) | Process for preparing 5-hydroxy-5-(3-aminoalkynyl) dibenzo [a, d] cyclohepta [1, 4] denes | |
| DD252829A5 (de) | Verfahren zur herstellung von 5-aminoalkyl-beta-corbelinderivaten | |
| US5137908A (en) | 4-azahexacyclododecane compounds | |
| CH628049A5 (en) | Process for the preparation of ergolene derivatives | |
| AT367420B (de) | Verfahren zur herstellung neuer vincaminderivate | |
| Lemke et al. | Isolation, synthesis, and evaluation of a series of indencarbazates as hypotensive agents | |
| US3969370A (en) | 1-Tertiary-alkyl-3-(substituted furyl)ureas as antihypertensive agents | |
| AT358191B (de) | Verfahren zur herstellung des neuen 11- -bromvincamins | |
| AT357563B (de) | Verfahren zur herstellung von neuen n-((1,2,4) oxadiazolo(2,3-a)pyrimidin-(7))carbamaten | |
| AT266140B (de) | Verfahren zur Herstellung von neuen Pyrazinverbindungen | |
| AT355583B (de) | Verfahren zur herstellung von neuen naphtyridinderivaten in form ihrer racemate oder ihrer optischen isomere und deren salzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |